Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Schizophrenia Research|May 26, 2005
An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term studyGeorges M Gharabawi, Cynthia A Bossie, Young Zhu, et al.Journal of Affective Disorders|April 2, 2008
Psychotic symptoms in patients with bipolar maniaCarla M Canuso, Cynthia A Bossie, Young Zhu, et al.International Journal of Geriatric Psychiatry|September 8, 2004
Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorderRobert A Lasser, Cynthia A Bossie, Young Zhu, et al.Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 7, 2007
Long-acting risperidone in young adults with early schizophrenia or schizoaffective illnessRobert A Lasser, Cynthia A Bossie, Young Zhu, et al.International Journal of Geriatric Psychiatry|May 2, 2007
The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trialsIra Katz, Peter-Paul de Deyn, Jacobo Mintzer, et al.International Clinical Psychopharmacology|June 4, 2005
Minimal injection site pain and high patient satisfaction during treatment with long-acting risperidoneJean-Pierre Lindenmayer, Kathleen Jarboe, Cynthia A Bossie, et al.Drugs & Aging|July 24, 2003
A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's diseaseGordon Wilcock, Ian Howe, Hilary Coles, et al.International Clinical Psychopharmacology|December 13, 2006
Patient-based and clinician-based support for the remission criteria in schizophreniaJohn P Docherty, Cynthia A Bossie, Bernard Lachaux, et al.Current Medical Research and Opinion|October 4, 2007
Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorderMarcia F T Rupnow, Andrew Greenspan, Georges M Gharabawi, et al.Alzheimer Disease and Associated Disorders|March 5, 2008
Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezilJames E Galvin, Barbara Cornblatt, Paul Newhouse, et al.Pageof 3